Life sciences news.

Explore the latest global highlights at the intersection of life sciences and digital innovation.

A flat illustration of a lung silhouette representing medical imaging.

Mar 17, 2026

LTTS launches NVIDIA-powered AI digital twin platform for precision diagnostics

L&T Technology Services (LTTS) has unveiled a new AI-driven digital twin platform aimed at enhancing precision diagnostics, particularly in the field of medical imaging.This innovative platform merges LTTS’ MedTech expertise with NVIDIA's advanced AI infrastructure, facilitating improved diagnostic accuracy and patient outcomes. A key feature is the lung digital twin solution, which integrates seamlessly with CT imaging workflows. Utilizing deep learning models, it creates a detailed 3D represen
Syringe with blood sample in a clinical lab setting

Mar 17, 2026

Study reveals limitations of large language models in medical diagnostics

A recent study highlights significant limitations of large language models (LLMs) in medical diagnostics, questioning their reliability in clinical settings.Artificial intelligence is making strides in healthcare, particularly with specialized algorithms designed for tasks like detecting diabetic eye disease or analyzing CT scans for early signs of cancer. However, the emergence of LLMs, such as ChatGPT and Claude, raises concerns regarding their applicability in medical diagnostics. A study con
A minimalist representation of a data stream in life sciences.

Mar 17, 2026

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

IQVIA has launched IQVIA.ai, a new agentic AI platform aimed at transforming operations within the life sciences sector. This platform, unveiled at NVIDIA GTC, leverages advanced technologies from NVIDIA to enhance decision-making and operational efficiency across clinical and commercial domains.IQVIA.ai integrates the company's extensive expertise in life sciences with NVIDIA's innovations, including the Nemotron and NeMo Agent Toolkit. The platform is designed to learn from complex operational
A mini-binder on a lab bench with protein samples in a dimly lit laboratory.

Mar 17, 2026

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

Viva Biotech is leveraging NVIDIA technology to enhance its AI-driven drug discovery process, particularly in designing mini-binders targeting the ActRIIA receptor, which is essential for addressing muscle wasting and lean mass issues.The collaboration emphasizes Viva Biotech's innovative "Lab-in-the-Loop" methodology, which integrates computational design with high-throughput protein production and biophysical testing. This approach demonstrates how in silico predictions can be validated throug
A flat illustration of a tumor cell and DNA strand in a minimalist style.

Mar 17, 2026

Lucence, DxD Hub and NCCS Launch UNITED 2.0 Precision Cancer Test

Lucence, in collaboration with DxD Hub and NCCS, has launched UNITED 2.0, a S$6 million initiative aimed at enhancing cancer diagnostics through advanced AI and comprehensive genomic analysis.This new research collaboration builds on the earlier UNITED 1.0 initiative, which utilized a tissue test to guide treatment decisions for cancer patients since 2021. The upgraded test, UNITED 2.0, will employ dual Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) to provide a more thoro
A high-performance GPU in a server rack in a dimly lit data center

Mar 16, 2026

Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions

Roche has unveiled a significant expansion of its AI infrastructure, launching the pharmaceutical industry's largest hybrid-cloud AI factory, now powered by over 3,500 NVIDIA Blackwell GPUs. This initiative aims to accelerate the development of new therapeutics and diagnostics solutions, aligning with Roche's vision of becoming an AI-driven healthcare organization.The newly introduced AI factory features 2,176 high-performance GPUs distributed across the U.S. and Europe. This infrastructure is d
Flat illustration of a GPU chip and a drug capsule

Mar 16, 2026

Inside Roche's 3,500-GPU AI factory racing new drugs to patients

Roche has unveiled an expansive AI factory, significantly enhancing its computational capabilities with over 3,500 NVIDIA GPUs to expedite drug development and diagnostics.On March 16, 2026, Roche announced the addition of 2,176 NVIDIA Blackwell GPUs, establishing the largest hybrid-cloud AI factory in the pharmaceutical sector. This initiative is a crucial part of Roche's strategy to integrate AI across various stages of healthcare, from research and development to manufacturing and commerciali
Minimalist illustration of a pipeline representing AI workflows

Mar 16, 2026

DDN Launches IndustrySync Pipelines for Financial Services and Life Sciences AI

DDN has introduced its IndustrySync Pipelines, designed to streamline AI deployment in the Financial Services and Life Sciences sectors, significantly reducing the time needed to move from concept to production.The newly launched IndustrySync Pipelines consist of validated AI workflows that can be quickly implemented on existing infrastructures, taking mere days instead of months. These pipelines are tailored to specific industry needs, ensuring that they align with desired business outcomes and
A drug compound in a glass vial on a lab bench with shelves of reagents in the background.

Mar 16, 2026

Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs

Roche is leveraging NVIDIA's AI technology to enhance drug discovery, diagnostics, and manufacturing processes significantly.Roche and Genentech are at the forefront of integrating artificial intelligence into their drug discovery efforts. The new infrastructure aims to streamline and accelerate various stages of drug development, emphasizing the importance of reducing the wait times for patients and their families. AI plays a crucial role in Genentech's Lab-in-the-Loop strategy, which connects
Flat illustration of a Nvidia GPU and circuit board in a minimalist style.

Mar 16, 2026

Roche Expands AI Power in Pharma R&D with Nvidia GPU Investment

Roche is significantly enhancing its artificial intelligence capabilities by investing in over 2,100 Nvidia GPUs, aimed at accelerating drug and diagnostics development.This expansion, which includes the deployment of 2,176 Nvidia Blackwell graphics processing units across the U.S. and Europe, positions Roche with the largest GPU footprint in the pharmaceutical industry. The additional computing power is expected to enhance various aspects of research and development, particularly in modeling, d